Filing Details

Accession Number:
0001140361-13-023999
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-04 19:07:17
Reporting Period:
2013-05-23
Filing Date:
2013-06-04
Accepted Time:
2013-06-04 18:07:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1196298 Nephros Inc NEPH Surgical & Medical Instruments & Apparatus (3841) 133971809
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1001391 E Charles Davidson C/O Wexford Capital Lp
411 West Putnam Ave.
Greenwich CT 06830
No No Yes No
1048462 Wexford Capital Lp 411 West Putnam Avenue
Suite 125
Greenwich CT 06830
No No Yes No
1048485 Joseph Jacobs C/O Wexford Capital Lp
411 West Putnam Avenue, Suite 125
Greenwich CT 06830
No No Yes No
1413621 Lambda Investors Llc 411 West Putnam Avenue
Suite 125
Greenwich CT 06830
No No Yes No
1472112 Wexford Gp Llc C/O Wexford Capital Lp
Suite 125
Greenwich CT 06830
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2013-05-23 2,992,884 $0.00 6,721,676 No 4 P Indirect Held directly by Lambda Investors LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held directly by Lambda Investors LLC
Footnotes
  1. On May 23, 2013, Lambda Investors LLC ('Lambda") purchased, pursuant to a rights offering with Nephros, Inc., 2,992,884 shares of Common Stock at a purchase price of $0.60 per share for a cost of $1,795,730.40.
  2. This form is jointly filed by Lambda, Wexford Capital LP ("Wexford"), Charles E. Davidson ("Davidson"), Joseph M. Jacobs ("Jacobs") and Wexford GP LLC ("Wexford GP"). The reported securities are held directly by Lambda and by Wexford. Wexford serves as manager, investment advisor or sub-advisor of Lambda, and as such may be deemed to share beneficial ownership of the securities beneficially owned by Lambda, but disclaims such beneficial ownership to the extent such beneficial ownership exceeds its pecuniary interest. Wexford GP, as the general partner of Wexford, may be deemed to share beneficial ownership of the securities beneficially owned by Lambda, but disclaims such ownership to the extent such beneficial ownership exceeds its pecuniary interest. (continued under Footnote (3) below).
  3. (continued from Footnote (2) above) Messrs. Davidson and Jacobs, as the controlling persons of Wexford GP, may be deemed to share beneficial ownership of any securities beneficially owned by Lambda for which Wexford serves as manager, investment advisor or sub-advisor, but disclaim such beneficial ownership to the extent such beneficial ownership exceeds their pecuniary interest.